Somnuek Sungkanuparph

Title: Somnuek Sungkanuparph: Innovator in Risk Assessment for Drug Reactions

Introduction

Somnuek Sungkanuparph is a notable inventor based in Bangkok, Thailand. He has made significant contributions to the field of pharmacogenetics, particularly in assessing the risk of cutaneous adverse drug reactions associated with antiretroviral agents. His work is crucial for improving patient safety and treatment outcomes.

Latest Patents

Somnuek Sungkanuparph holds a patent titled "Risk assessment for cutaneous adverse drug reactions from antiretroviral agent." This invention provides a method for predicting the risk of patients developing cutaneous adverse drug reactions to non-nucleoside reverse transcriptase inhibitors, such as nevirapine. The method utilizes the HLA-B*3505 allele and/or polymorphisms in the CCHCR1 gene to assess risk effectively.

Career Highlights

Throughout his career, Somnuek has worked with prestigious institutions, including Mahidol University and Riken Corporation. His experience in these organizations has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Somnuek has collaborated with esteemed colleagues, including Sasisopin Kiertiburanakul and Thanyachai Sura. These partnerships have enhanced his research efforts and broadened the impact of his work in the field.

Conclusion

Somnuek Sungkanuparph is a pioneering inventor whose work in risk assessment for drug reactions is vital for enhancing patient care. His contributions to pharmacogenetics continue to influence the medical field positively.